Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19. - Valdez‑Cruz, Norma A.; Rosiles-Becerril, Diego; Martínez-Olivares, Constanza E.; García‑Hernández, Enrique; Cobos-Marín, Laura; Garzón, Daniel; López-Salas, Francisco E.; Zavala, Guadalupe; Luviano, Axel; Olvera, Alejandro; Alagón, Alejandro; Ramírez, Octavio T.; et al. (Microbial Cell Factories, 2024)